Terrance McGuire's Net Worth

$253 Million

Who is Terrance McGuire?

Terrance McGuire has an estimated net worth of $253 Million. This is based on reported shares across multiple companies, which include TechTarget Inc, ALNYLAM PHARMACEUTICALS, INC., POLARIS INDUSTRIES INC/MN, MOMENTA PHARMACEUTICALS INC, Phreesia, Inc., ACUSPHERE INC, LogMeIn, Inc., BIND Therapeutics, Inc, Seer, Inc., Invivyd, Inc., Pulmatrix, Inc., Alector, Inc., IRONWOOD PHARMACEUTICALS INC, TREVENA INC, Lyra Therapeutics, Inc., Cyclerion Therapeutics, Inc., ALIMERA SCIENCES INC, Arsanis, Inc., ACCELERON PHARMA INC, INTERNET BRANDS, INC., Sirtris Pharmaceuticals, Inc., and DECODE GENETICS INC.

SEC CIK

Terrance McGuire's CIK is 0001117003

Past Insider Trading and Trends

2015 was Terrance McGuire's most active year for acquiring shares with 36 total transactions. Terrance McGuire's most active month to acquire stocks was the month of May. 2004 was Terrance McGuire's most active year for disposing of shares, totalling 52 transactions. Terrance McGuire's most active month to dispose stocks was the month of November. 2019 saw Terrance McGuire paying a total of $10,017,872.00 for 17,515,626 shares, this is the most they've acquired in one year. In 2010 Terrance McGuire cashed out on 9,416,453 shares for a total of $24,000,000.00, their largest year based on trade value.